Skip to content
This project aims to monitor the impact of the vaccine Prevenar13 on otitis media among Indigenous Australian children in the Northern Territory and Western Australia in 2013.
Currently, Prevenar13 immunises against seven different types of bacteria which cause otitis media, but there are other types that are not immunised against, and the prevalence of these is increasing.
The objectives of this project are to:
This project is part of ongoing monitoring of Prevenar13 efficacy and is an initiative of the Menzies School of Health Research and Pfizer.
Abstract adapted from Menzies School of Health Research
Menzies School of Health Research
John Matthews Building
Royal Darwin Hospital Campus
Casuarina NT 0810
PO Box 41096
Casuarina NT 0811
Ph: (08) 8946 8600
Fax: (08) 8946 8464